Aurora Investment Counsel Purchases Shares of 20,056 The Cooper Companies, Inc. $COO

Key Points

• Aurora Investment Counsel has purchased 20,056 shares of The Cooper Companies, Inc., valued at approximately $1.427 million, during the second quarter.
• Insiders have made significant stock purchases, with COO Gerard H. Warner III acquiring 1,450 shares and Director Lawrence Erik Kurzius buying 2,000 shares, indicating increased confidence in the company's future.
• The Cooper Companies has announced a $2 billion stock buyback program, allowing it to repurchase up to 15.4% of its shares, reflecting the belief that its stock is undervalued.

Aurora Investment Counsel purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,056 shares of the medical device company's stock, valued at approximately $1,427,000.

Several other large investors also recently added to or reduced their stakes in COO. Zions Bancorporation National Association UT acquired a new stake in Cooper Companies during the 1st quarter valued at $33,000. J.Safra Asset Management Corp raised its stake in Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company's stock valued at $36,000 after purchasing an additional 340 shares during the period. GKV Capital Management Co. Inc. acquired a new stake in Cooper Companies during the 1st quarter valued at $40,000. Larson Financial Group LLC raised its stake in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after purchasing an additional 664 shares during the period. Finally, HM Payson & Co. raised its stake in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after purchasing an additional 532 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cooper Companies

In related news, COO Gerard H. Warner III acquired 1,450 shares of the business's stock in a transaction dated Friday, September 5th. The stock was acquired at an average price of $69.23 per share, with a total value of $100,383.50. Following the completion of the transaction, the chief operating officer owned 18,319 shares of the company's stock, valued at approximately $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the business's stock in a transaction dated Monday, September 29th. The shares were bought at an average cost of $68.39 per share, with a total value of $136,780.00. Following the transaction, the director directly owned 5,777 shares of the company's stock, valued at $395,089.03. The trade was a 52.95% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 17,975 shares of company stock valued at $1,216,346 in the last three months. Company insiders own 1.98% of the company's stock.

Cooper Companies Stock Up 4.2%

COO stock opened at $74.99 on Tuesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.04. The company has a 50-day moving average of $69.60 and a two-hundred day moving average of $73.19. The stock has a market capitalization of $14.91 billion, a price-to-earnings ratio of 36.94, a price-to-earnings-growth ratio of 1.89 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies declared that its board has initiated a stock buyback program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its stock is undervalued.

Analysts Set New Price Targets

COO has been the topic of a number of research reports. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Cooper Companies in a research note on Wednesday, October 8th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. Needham & Company LLC reaffirmed a "buy" rating and issued a $94.00 price target on shares of Cooper Companies in a research note on Thursday, August 28th. Piper Sandler decreased their price objective on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. Finally, The Goldman Sachs Group set a $64.00 price objective on shares of Cooper Companies and gave the stock a "sell" rating in a report on Wednesday, October 1st. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $84.77.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.